
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.4B | -- | -- | $2.37 | -- |
08/06/2025 | Q2 | $1.4B | -- | -- | $2.27 | -- |
05/14/2025 | Q1 | $1.5B | $1.5B | $1.48 | $2.60 | -$1.12 |
02/05/2025 | Q4 | $1.4B | $1.4B | $1.75 | $2.32 | -$0.57 |
11/06/2024 | Q3 | $1.3B | $1.3B | $1.51 | $2.13 | -$0.62 |
08/06/2024 | Q2 | $1.3B | $1.3B | $1.46 | $1.98 | -$0.52 |
05/08/2024 | Q1 | $1.4B | $1.4B | -$0.01 | $2.41 | -$2.42 |
02/07/2024 | Q4 | $1.3B | $1.4B | $1.42 | $2.17 | -$0.75 |
11/08/2023 | Q3 | -- | -- | $1.16 | $2.00 | -$0.84 |
08/01/2023 | Q2 | -- | -- | $1.25 | $1.86 | -$0.61 |
05/10/2023 | Q1 | -- | -- | $1.88 | $2.15 | -$0.27 |
02/08/2023 | Q4 | -- | -- | $1.24 | $2.19 | -$0.95 |
11/09/2022 | Q3 | -- | -- | -$3.15 | $1.98 | -$5.13 |
08/02/2022 | Q2 | -- | -- | $1.10 | $1.90 | -$0.80 |
05/11/2022 | Q1 | -- | -- | $0.52 | $2.02 | -$1.50 |
02/08/2022 | Q4 | -- | -- | $1.42 | $1.96 | -$0.54 |
11/02/2021 | Q3 | -- | -- | $0.69 | $1.82 | -$1.13 |
08/09/2021 | Q2 | -- | -- | -$0.24 | $1.49 | -$1.73 |
05/18/2021 | Q1 | -- | -- | $1.02 | $1.80 | -$0.78 |
02/02/2021 | Q4 | -- | -- | $1.33 | $1.54 | -$0.21 |
11/02/2020 | Q3 | -- | -- | $1.23 | $1.27 | -$0.04 |
08/03/2020 | Q2 | -- | -- | $1.03 | $0.98 | $0.05 |
05/13/2020 | Q1 | -- | -- | $1.44 | $1.58 | -$0.14 |
02/10/2020 | Q4 | -- | -- | $1.23 | $1.42 | -$0.19 |
11/04/2019 | Q3 | -- | -- | $1.11 | $1.25 | -$0.14 |
08/05/2019 | Q2 | -- | -- | $1.23 | $1.11 | $0.12 |
05/13/2019 | Q1 | -- | -- | $1.53 | $1.43 | $0.10 |
02/12/2019 | Q4 | -- | -- | $1.26 | $1.25 | $0.01 |
11/06/2018 | Q3 | -- | -- | $1.10 | $1.09 | $0.01 |
08/08/2018 | Q2 | -- | -- | $1.00 | $0.99 | $0.01 |
05/09/2018 | Q1 | -- | -- | $1.24 | $1.22 | $0.02 |
02/07/2018 | Q4 | -- | -- | $1.12 | $1.07 | $0.06 |
11/01/2017 | Q3 | -- | -- | $0.94 | $0.94 | -$0.00 |
08/08/2017 | Q2 | -- | -- | $0.85 | $0.80 | $0.05 |
05/09/2017 | Q1 | -- | -- | $1.11 | $1.06 | $0.05 |
02/07/2017 | Q4 | -- | -- | $0.98 | $1.04 | -$0.06 |
11/02/2016 | Q3 | -- | -- | $0.89 | $0.90 | -$0.01 |
08/09/2016 | Q2 | -- | -- | $0.79 | $0.78 | $0.01 |
05/18/2016 | Q1 | -- | -- | $0.90 | $1.01 | -$0.11 |
02/09/2016 | Q4 | -- | -- | $0.98 | $0.94 | $0.04 |
10/30/2015 | Q3 | -- | -- | $0.83 | $0.76 | $0.07 |
Steris PLC reported $1.5B worth of top line sales in its most recent quarter.
Steris PLC announced earnings per share of $1.48 which represents a miss of analyst forecast a $2.60 per share.
Steris PLC reported $641.2M that represents $6.49 per share over the last quarter.
Steris PLC's earnings are forecast to grow from $6.20 per share to $9.06 per share next year representing an increase of 62.03%.
Steris PLC's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.